These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22161686)

  • 1. Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study.
    Sikjaer T; Rejnmark L; Thomsen JS; Tietze A; Brüel A; Andersen G; Mosekilde L
    J Bone Miner Res; 2012 Apr; 27(4):781-8. PubMed ID: 22161686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
    Gafni RI; Brahim JS; Andreopoulou P; Bhattacharyya N; Kelly MH; Brillante BA; Reynolds JC; Zhou H; Dempster DW; Collins MT
    J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.
    Underbjerg L; Malmstroem S; Sikjaer T; Rejnmark L
    J Bone Miner Res; 2018 Mar; 33(3):467-477. PubMed ID: 29087612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84).
    Agarwal S; McMahon DJ; Chen J; Brossfield AV; Fernando J; Bilezikian JP; Cusano NE; Rubin MR
    J Bone Miner Res; 2023 Apr; 38(4):480-492. PubMed ID: 36726204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone imaging in hypoparathyroidism.
    Silva BC; Rubin MR; Cusano NE; Bilezikian JP
    Osteoporos Int; 2017 Feb; 28(2):463-471. PubMed ID: 27577725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
    Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L;
    J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
    Cipriani C; Pepe J; Silva BC; Rubin MR; Cusano NE; McMahon DJ; Nieddu L; Angelozzi M; Biamonte F; Diacinti D; Hans D; Minisola S; Bilezikian JP
    J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.
    Chen Q; Kaji H; Iu MF; Nomura R; Sowa H; Yamauchi M; Tsukamoto T; Sugimoto T; Chihara K
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4655-8. PubMed ID: 14557436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.
    Rubin MR; Dempster DW; Sliney J; Zhou H; Nickolas TL; Stein EM; Dworakowski E; Dellabadia M; Ives R; McMahon DJ; Zhang C; Silverberg SJ; Shane E; Cremers S; Bilezikian JP
    J Bone Miner Res; 2011 Nov; 26(11):2727-36. PubMed ID: 21735476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture.
    Hong AR; Lee JH; Kim JH; Kim SW; Shin CS
    Calcif Tissue Int; 2019 Apr; 104(4):382-389. PubMed ID: 30659307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.
    Rubin MR; Zwahlen A; Dempster DW; Zhou H; Cusano NE; Zhang C; Müller R; Bilezikian JP
    J Bone Miner Res; 2016 May; 31(5):1082-8. PubMed ID: 26724790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
    Cipriani C; Abraham A; Silva BC; Cusano NE; Rubin MR; McMahon DJ; Zhang C; Hans D; Silverberg SJ; Bilezikian JP
    Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
    Duan Y; De Luca V; Seeman E
    J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
    Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
    J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB; Kisiel M; Adachi JD; Fraher LJ; Watson PH
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.